Furthermore, the expression of RNF183 was up-regulated in IECs of IBD patients and TNBS-induced colitis mouse model, and promoted NF-κB signaling mediated intestinal inflammation by increasing ubiquitination -proteasome degradation of IκB (105). Here, NFKB1 is linked to inflammatory bowel disease.